Since the multiplex immunostaining will be challenging with additional markers along with existing CD8 and DAPI, it will require a completely different approach of extracting and flow cytometry analysis of tumour-infiltrated T cells and will be a significantly time-consuming exercise considering these mouse models. This evidence concerns the gene CD8A and neoplasm.